86 related articles for article (PubMed ID: 12505440)
1. Nickel and cobalt activate complement factor C3 faster than magnesium.
Acevedo F; Vesterberg O
Toxicology; 2003 Mar; 185(1-2):9-16. PubMed ID: 12505440
[TBL] [Abstract][Full Text] [Related]
2. C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium.
Fishelson Z; Müller-Eberhard HJ
J Immunol; 1982 Dec; 129(6):2603-7. PubMed ID: 6923908
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the initial C3 convertase of the alternative pathway of human complement.
Fishelson Z; Pangburn MK; Müller-Eberhard HJ
J Immunol; 1984 Mar; 132(3):1430-4. PubMed ID: 6559201
[TBL] [Abstract][Full Text] [Related]
4. Simple quantification of complement factors C3 and C3b using separation by isotachophoresis.
Acevedo F
Electrophoresis; 1999 Mar; 20(3):469-72. PubMed ID: 10217155
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
Medof ME; Kinoshita T; Nussenzweig V
J Exp Med; 1984 Nov; 160(5):1558-78. PubMed ID: 6238120
[TBL] [Abstract][Full Text] [Related]
6. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
Mayes JT; Schreiber RD; Cooper NR
J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
[TBL] [Abstract][Full Text] [Related]
7. Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity.
Kerr LD; Adelsberg BR; Schulman P; Spiera H
Arthritis Rheum; 1989 Nov; 32(11):1406-13. PubMed ID: 2818657
[TBL] [Abstract][Full Text] [Related]
8. Human monocyte spreading induced by factor Bb of the alternative pathway of complement activation. A possible role for C5 in monocyte spreading.
Sundsmo JS; Götze O
J Exp Med; 1981 Sep; 154(3):763-77. PubMed ID: 6912276
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
Farries TC; Lachmann PJ; Harrison RA
Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783
[TBL] [Abstract][Full Text] [Related]
10. Activation and fragmentation of the third (C3) and the fourth (C4) components of complement: generation and isolation of physiologically relevant fragments C3c and C4c.
Janatova J; Gobel RJ
J Immunol Methods; 1985 Dec; 85(1):17-26. PubMed ID: 4078308
[TBL] [Abstract][Full Text] [Related]
11. C3 activation by a new factor B-dependent enzyme detected in culture supernatant from guinea-pig peritoneal macrophages.
Beuscher HU; Brade V
Immunology; 1986 Aug; 58(4):545-51. PubMed ID: 3089917
[TBL] [Abstract][Full Text] [Related]
12. Complement C3 proteins in psoriasis.
Acevedo F; Hammar H
Br J Dermatol; 1989 Sep; 121(3):329-35. PubMed ID: 2508741
[TBL] [Abstract][Full Text] [Related]
13. Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3.
Pangburn MK; Müller-Eberhard HJ
Ann N Y Acad Sci; 1983; 421():291-8. PubMed ID: 6586103
[TBL] [Abstract][Full Text] [Related]
14. Effects of lysine and glutamic acid or [corrected] Mg++ on the conformations of C3 and B, and the activation of the alternative complement pathway.
Takada A; Takada Y; Makino Y; Sugawara Y; Shirahama S
Complement; 1987; 4(2):110-9. PubMed ID: 2887399
[TBL] [Abstract][Full Text] [Related]
15. The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells.
Olesen EH; Johnson AA; Damgaard G; Leslie RG
Immunology; 1998 Feb; 93(2):177-83. PubMed ID: 9616366
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of C3 and factor B in patients with congenital factor I deficiency.
Rasmussen JM; Teisner B; Brandt J; Brandslund I; Gry H
J Clin Lab Immunol; 1990 Feb; 31(2):59-67. PubMed ID: 1966986
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb.
Leijh PC; van den Barselaar MT; Daha MR; van Furth R
J Immunol; 1982 Jul; 129(1):332-7. PubMed ID: 6979568
[TBL] [Abstract][Full Text] [Related]
18. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
19. The attachment of serum- and plasma-derived C3 to solid-phase immune aggregates and its relation to complement-mediated solubilization of immune complexes.
Baatrup G; Svehag SE; Jensenius JC
Scand J Immunol; 1986 Apr; 23(4):397-406. PubMed ID: 3486458
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
